Has Nishant Ranawat, MD received payments from drug or device companies?

Yes. Drug and device makers reported $6,127 in general payments to Nishant Ranawat, MD across 54 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Nishant Ranawat, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Nishant Ranawat, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Nishant Ranawat, MD

Vascular Neurology · Shenandoah, TXNPI 1366658627

Payments from drug & device makers

What this record shows

9 manufacturers reported payments, led by Penumbra, Inc. at 48.4% of the total. Reporting peaked in 2019 at $4,119 and has fallen 99.1% since, to $37 in 2024.

$6,127in general payments, 2019–2025

Across 54 payments — averaging $113.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Penumbra, Inc.$3K
Medtronic$1K
Siemens Medical Solutions USA, Inc.$1K
Philips North America LLC$294
Stryker$207
AstraZeneca$98
plus $146 from 3 others

What the payments were for

Travel & lodging$3,51957%
Food & beverage$2,60843%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Penumbra, Inc.	19	$2,964
Medtronic	18	$1,214
Siemens Medical Solutions USA, Inc.	6	$1,205
Philips North America LLC	3	$294
Stryker	3	$207
AstraZeneca	1	$98
Microvention, Inc.	2	$80
Qapel Medical Inc	1	$37
AbbVie	1	$30

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,127 in reported general payments places this provider in the 70th percentile of 76 vascular neurology providers in Texas.

See all vascular neurology providers in Texas →

Medicare billing

Part B allowed, 2024

$23,754

Medicare patients

Services billed

132

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Telmisartan	14	$164
Atorvastatin Calcium	11	$68

Paid to pharmacies, not to this prescriber.

Other vascular neurology in Shenandoah

Nhu BruceShenandoah$10K
Shyam PanchalShenandoah$780
Keval ShahShenandoah$719
Ameer HassanHarlingen$1M
John VolpiHouston$407K
Lee BirnbaumSan Antonio$195K
Amrou SarrajHouston$182K
Sunil ShethHouston$54K
Steven WarachAustin$32K
Jefferson MileyAustin$28K

See the full list for Texas →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →